Form 10-K CYTOKINETICS INC For: Dec 31
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260226/AU2LL22CZZ2RA9ZU22ZA2ZYSQQGGZZ22Z286
Filed on: February 26, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cytokinetics Announces Call for Proposals for Annual Corporate Giving Program
- Akeso's Gumokimab (AK111, Anti-IL-17) Approved by NMPA for Moderate-to-Severe Plaque Psoriasis, Bolstering Its Autoimmune Disease Portfolio
- Vantage Secures Position on the Fortune Crypto Innovators List, Highlighting Cross-Market Trading Innovation
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
